These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36228936)

  • 21. Papulo-pustular eruption during cetuximab treatment.
    Satta R; Cuccuru MA; Pirodda C; Cottoni F
    G Ital Dermatol Venereol; 2008 Feb; 143(1):87-8. PubMed ID: 18833056
    [No Abstract]   [Full Text] [Related]  

  • 22. A systematic review of oral retinoids for treatment of acneiform eruptions induced by epidermal growth factor receptor inhibitors.
    Bierbrier R; Lam M; Pehr K
    Dermatol Ther; 2022 May; 35(5):e15412. PubMed ID: 35220635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Choosing between isotretinoin and acitretin for epidermal growth factor receptor inhibitor and small molecule tyrosine kinase inhibitor acneiform eruptions.
    Costello CM; Hill HE; Brumfiel CM; Yang YW; Swanson DL
    J Am Acad Dermatol; 2021 Mar; 84(3):840-841. PubMed ID: 33039483
    [No Abstract]   [Full Text] [Related]  

  • 24. Acneiform eruption induced by epidermal growth factor receptor inhibitors in patients with solid tumours.
    Jacot W; Bessis D; Jorda E; Ychou M; Fabbro M; Pujol JL; Guillot B
    Br J Dermatol; 2004 Jul; 151(1):238-41. PubMed ID: 15270903
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy, tolerability and impact on quality of life of clindamycin phosphate and benzoyl peroxide for the treatment of cetuximab-associated acneiform eruption in patients with metastatic colorectal cancer.
    Vaccaro M; Guarneri F; Borgia F; Pollicino A; Altavilla G; Cannavò SP
    J Dermatolog Treat; 2016; 27(2):148-52. PubMed ID: 26313697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased infection rates associated with tetracycline therapy given for epidermal growth factor receptor inhibitor (EGFRI)-associated acneiform eruption: A retrospective study of data from two cancer centers.
    Magnino MZ; Perry DJ; Subramaniam DS; DeKlotz CMC
    J Am Acad Dermatol; 2020 Feb; 82(2):486-488. PubMed ID: 31279812
    [No Abstract]   [Full Text] [Related]  

  • 27. Vitamin K1 cream significantly reduces incidence and severity of cetuximab-related acneiform skin rash in women: a post hoc analysis of the EVITA trial.
    Gaiser MR; Lorenzen S; Merx K; Trojan J; Ocvirk J; Ettrich TJ; Al-Batran SE; Schulz H; Homann N; Feustel HP; Schatz M; Kripp M; Schulte N; Heeger S; Vlassak S; Koch W; Hofheinz RD
    Ann Oncol; 2018 Dec; 29(12):2393-2395. PubMed ID: 30307464
    [No Abstract]   [Full Text] [Related]  

  • 28. Cetuximab-induced acne.
    Molinari E; De Quatrebarbes J; André T; Aractingi S
    Dermatology; 2005; 211(4):330-3. PubMed ID: 16286741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A retrospective chart review on oral retinoids as a treatment for epidermal growth factor receptor inhibitor- and mitogen-activated protein kinase kinase inhibitor-induced acneiform eruptions.
    Andrews ED; Garg N; Patel AB
    J Am Acad Dermatol; 2020 Apr; 82(4):998-1000. PubMed ID: 31604105
    [No Abstract]   [Full Text] [Related]  

  • 30. EGFR inhibitors: clinical aspects, risk factors and biomarkers for acneiform eruptions and other mucosal and cutaneous adverse effects.
    Recuero JK; Fitz JR; Pereira AA; Bonamigo RR
    An Bras Dermatol; 2023; 98(4):429-439. PubMed ID: 36990917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Duration of Oral Antibiotics Administration for Cetuximab-Induced Acneiform Eruption.
    Park JH; Choi Y; Kim HJ; Oh SJ; Lee DY; Lee JH; Lee JH
    Dermatology; 2021; 237(3):457-463. PubMed ID: 33302268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acneiform rash due to epidermal growth factor receptor inhibitors: high-level laser therapy as an innovative approach.
    Gobbo M; Ottaviani G; Mustacchi G; Di Lenarda R; Biasotto M
    Lasers Med Sci; 2012 Sep; 27(5):1085-90. PubMed ID: 22120470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Instrumental evaluation sensitively detects subclinical skin changes by the epidermal growth factor receptor inhibitors and risk factors for severe acneiform eruption.
    Kikuchi K; Nozawa K; Yamazaki N; Nakai Y; Higashiyama A; Asano M; Fujiwara Y; Kanda S; Ohe Y; Takashima A; Boku N; Inoue A; Takahashi M; Mori T; Taguchi O; Inoue Y; Mizutani H
    J Dermatol; 2019 Jan; 46(1):18-25. PubMed ID: 30402978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Grover's disease induced by cetuximab.
    Tscharner GG; Bühler S; Borner M; Hunziker T
    Dermatology; 2006; 213(1):37-9. PubMed ID: 16778425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prophylactic versus reactive treatment of acneiform skin rashes from epidermal growth factor receptor inhibitors in metastatic colorectal cancer.
    Dascalu B; Kennecke HF; Lim HJ; Renouf DJ; Ruan JY; Chang JT; Cheung WY
    Support Care Cancer; 2016 Feb; 24(2):799-805. PubMed ID: 26184500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Acute acneform eruption secondary to cetuximab with good response to metronidazole].
    Jiménez-Puya R; Gómez-García F; Rodríguez-Bujaldón A; Moreno-Giménez JC
    Actas Dermosifiliogr; 2007 Nov; 98(9):648-9. PubMed ID: 17961460
    [No Abstract]   [Full Text] [Related]  

  • 37. [Acneiform eruption secondary to cetuximab with pseudomalignant histopathological changes].
    Vidal-Olmo I; Bassas-Vila J; Herrera-Acosta E; Umbert-Millet P
    Actas Dermosifiliogr; 2008 Mar; 99(2):159-60. PubMed ID: 18346444
    [No Abstract]   [Full Text] [Related]  

  • 38. Demodex-Positive Acneiform Eruption Responsive to Ivermectin in a Patient Taking an Epidermal Growth Factor Inhibitor.
    Parker TB; Blechman AB; Wilson BB
    JAMA Dermatol; 2017 Sep; 153(9):939-940. PubMed ID: 28593247
    [No Abstract]   [Full Text] [Related]  

  • 39. [Unilateral acneiform rash in facial palsy].
    Kerob D; Hennequin V; Bousquet G; Behm E; Lebbe C
    Ann Dermatol Venereol; 2010 Nov; 137(11):727-9. PubMed ID: 21074658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A double-blind, placebo-controlled study of the safety and efficacy of vitamin K1 ointment for the treatment of patients with cetuximab-induced acneiform eruption.
    Hashimoto H; Iwasa S; Yanai T; Honma Y; Kato K; Hamaguchi T; Yamada Y; Shimada Y; Namikawa K; Tsutsumida A; Yamazaki N; Yamamoto H
    Jpn J Clin Oncol; 2013 Jan; 43(1):92-4. PubMed ID: 23136238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.